V018-3696 Screening compound: 4-[6-BENZOYL-2-(PIPERIDIN-1-YL)-5H,6H,7H,8H-PYRIDO[4,3-D]PYRIMIDIN-4-YL]MORPHOLINE

V018-3696 Screening compound: 4-[6-BENZOYL-2-(PIPERIDIN-1-YL)-5H,6H,7H,8H-PYRIDO[4,3-D]PYRIMIDIN-4-YL]MORPHOLINE
V018-3696 Screening compound: 4-[6-BENZOYL-2-(PIPERIDIN-1-YL)-5H,6H,7H,8H-PYRIDO[4,3-D]PYRIMIDIN-4-YL]MORPHOLINE alternative view

Chemical Structure Depiction of ChemDiv screening compound V018-3696
4-[6-BENZOYL-2-(PIPERIDIN-1-YL)-5H,6H,7H,8H-PYRIDO[4,3-D]PYRIMIDIN-4-YL]MORPHOLINE

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V018-3696

Molecular Formula

C23H29N5O2 (C23 H29 N5 O2)

Compound Name

4-[6-BENZOYL-2-(PIPERIDIN-1-YL)-5H,6H,7H,8H-PYRIDO[4,3-D]PYRIMIDIN-4-YL]MORPHOLINE

IUPAC name

n/a

SMILES

O=C(c1ccccc1)N1Cc2c(N3CCOCC3)nc(N3CCCCC3)nc2CC1

InChI

InChI=1S/C23H29N5O2/c29-22(18-7-3-1-4-8-18)28-12-9-20-19(17-28)21(26-13-15-30-16-14-26)25-23(24-20)27-10-5-2-6-11-27/h1,3-4,7-8H,2,5-6,9-17H2

InChI Key

YDTMWHVZCIPMKV-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19909104

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

407.52

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.131

Distribution Coefficient, logD

3.063

Water Solubility, LogSw

-3.08

Polar Surface Area

50.294

Acid Dissociation Constant (pKa)

20.03

Base Dissociation Constant (pKb)

6.63

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

52.20

V018-3696 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

GPCR Targeted Library (31838 compounds)

PI3K-Targeted Library (17255 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • GPCR
  • Kinases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with V018-3696 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V018-3696?
Check Price and Availability of V018-3696, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V018-3696 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V018-3696
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V018-3696
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V018-3696 available by request